| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |